Grupo 3: Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Código de grupo: 6.03
Tipo de grupo: Consolidado
Descripción del grupo: Genética y clínica de las neoplasias hematológicas y el trasplante hematopoyético
Jefes de Grupo: Ramón García Sanz – Ismael Buño Borde

Integrantes del grupo
Investigadores y personal de apoyo
ANGUITA VELASCO JAVIER Established Researcher
BAILEN ALMOROX REBECA First Stage Researcher
BASTOS OREIRO MARIANA BEATRIZ Established Researcher
BARDON CANCHO EDUARDO JESÚS First Stage Researcher
BELENDEZ BIELER CRISTINA Established Researcher
BORREGO VILLEGAS LAURA Clinical Trial Manager
BUÑO BORDE ISMAEL Leading Researcher
CARBONELL MUÑOZ DIEGO Recognised Researcher
CATALÁ BARDISA EVA First Stage Researcher
CELA DE JULIÁN ELENA Established Researcher
CHICANO LAVILLA MARIA Recognised Researcher
DE LA IGLESIA SAN SEBASTIAN ISMAEL First Stage Researcher
ENCINAS RODRÍGUEZ CRISTINA First Stage Researcher
FERNANDEZ DE CORDOBA OÑATE SARA First Stage Researcher
FERNANDEZ GONZALEZ RAQUEL First Stage Researcher
GARCIA GARCIA ANA MARIA
GARCIA MORIN MARINA Recognised Researcher
GARCIA SANZ RAMON Leading Researcher
GARRIDO COLINO CARMEN Established Researcher
GAYOSO CRUZ JORGE Established Researcher
GOMEZ CENTURION IGNACIO First Stage Researcher
GONZALEZ GUERRERO ALBA First Stage Researcher
HERNANDEZ MARTIN MARTA MARIA Clinical Trial Manager
HUERTA ARAGONES JORGE First Stage Researcher
KWON KIM MI Established Researcher
LOPEZ ESTEBAN MIGUEL First Stage Researcher
MAQUEDA PERUCHA LAURA First Stage Researcher
MARCO SANCHEZ JOSE MANUEL First Stage Researcher
MARTINEZ GARCIA MARIA First Stage Researcher
MARTINEZ LAPERCHE CAROLINA Established Researcher
MAS ESPINOSA VERONICA
MATA FERNANDEZ CRISTINA Established Researcher
MEDIN DE BLOCK HILDA GABRIELA First Stage Researcher
MONTERO BALLESTA CRISTINA First Stage Researcher
MORENO CARBONELL MARTA First Stage Researcher
MUÑOZ MARTINEZ CRISTINA Clinical Trial Manager
NEGRETE GUTIERREZ LIDIA First Stage Researcher
OARBEASCOA ROYUELA GILLEN First Stage Researcher
PRIETO MEDINA MARIA DEL MAR First Stage Researcher
SANCHEZ GARCIA TAMARA
SEGURA GONZALEZ MARIA First Stage Researcher
SUAREZ GONZALEZ JULIA Recognised Researcher
Líneas de Investigación
Axis 1: Hematology-oncology in adults

L1: Transplantation of hematopoietic progenitor cells.

1.1. Transplantation of nonconventional hematopoietic progenitor cells (haploidentical, dual).

1.2. Transplantation of hematopoietic progenitor cells in patients with AIDS.

1.3. Cell therapy (mesenchymal, NK cells, etc.)

1.4. Follow-up of transplantation of hematopoietic progenitors (genetics and flow cytometry).

1.5. Biomarkers for prediction of post-transplant complications (genetic polymorphism, proteins, etc.).

1.6. Gene/cell therapy with CAR-T cells

L2: Myeloid neoplasms: Acute myeloid leukemia and myelodysplastic syndrome.

2.1. Treatment with next-generation drugs.

2.2. Genomics of the tumour cell.

2.3. In vitro drug resistance studies.

2.4. Cytotoxicity studies with NK.

L3: High-grade lymphomas.

3.1. Liquid biopsy (free DNA in plasma) in high-grade lymphomas.

L4: Chronic myeloid leukemia.

4.1. Studies on discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia.

L5: Genetics of hematologic neoplasms.

5.1. Genetic markers for diagnosis, prognosis and targeted treatment.

5.2. Genomics of hematologic neoplasms: next-generation sequencing.

5.3. Leukemogenesis models.

5.4 Germ genomic alterations

L6: Clinical research (clinical trials).

6.1. Molecular targets in the treatment of hemato-oncology patients.

6.2. Monoclonal antibodies in the treatment of hematology-oncology patients.

6.3. Cell therapy (mesenchymal, NK cells, etc.

6.4. Gene/cell therapy with CAR-T cells

L7: Electronic management of clinical information.

Axis 2: Paediatric hematology-oncology

L1: Hemoglobinopathies. (CSUR de Eritropatología Hereditaria)

1.1 Transplantation of hematopoietic progenitors in hemoglobinopathies

1.2 Clinical monitoring of sickle cell disease from neonatal screening

1.3 Erythrocytapheresis in the Paediatric Sickle Cell Patient

L2: Adjuvant therapy in paediatric hematology-oncology.

L3: Fanconi anemia.

L3.1 Multidisciplinary follow-up in Fanconi’s Anemia

L4: Solid tumours in children.

L5: Leukemia in children.

 

First decile publications 9 105,8
First quartile publications 28 246,1
Second quartile publications 18 73,7
Third quartile publications 12 31,4
Total publications (including those without IF) 68 362,2

 

 

 

 

 

 

 

 

 

 

 

SUBIR ↑